< Back to latest news & events

Event

Webinar: A comparison of IP Practice in EU, US and JP for new medical use and method of treatment patenting

May 2022

Event date: 27th June 2022

HGF, Shiga and Wolf Greenfield and hosting a webinar to compare the IP Practice in EU, US and JP for new medical use and method of treatment patenting.

Our expert speakers will compare and contrast the opportunities and restrictions for patenting of new medical uses in the three jurisdictions with a case study that will consider new medical uses defined by new mechanism of actions; new dosage or treatment regimens; new medical uses defined by newly identified patient subgroup; and a new combination uses.

Date

27th June, 2022

Time

1pm (BST)

2pm (CEST)

9pm (JST)

8am (EST)

Speakers
  • Masato Iida, Shiga
  • Jeffrey D. Hsi, Wolf Greenfield
  • Laurence Gainey, HGF
  • Mike Nelson, HGF

Attendees

Michael
Nelson

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

WIPR Diversity Top 100 2025

HGF’s European Patent Attorney Alexandra Wood has been listed in World IP Review’s (WIPR) Diversity Top 100 2025 World IP Review’s Diversity in IP listings 2025 recognises and celebrates people …

Read article

INTA 2025 Annual Meeting Live

The HGF European team will be attending the INTA Annual Meeting Live, which will take place on 17th-21st May in San Diego, US. The conference will connect some of the …

Read article

HGF wins big at the Managing IP EMEA Awards Ceremony 2025

The Annual Managing IP Awards: EMEA Awards 2025 were announced last night, and HGF are proud to have won 7 awards. The Managing IP Awards are highly recognised and respected …

Read article

Plant Patent Infringement in the US Relies on Evidence of Asexual Reproduction

A recent case in the US District Court for the Northern District of Texas (Dallas Division) once again highlights how important the initial pleadings and evidence in patent infringement cases …

Read article

Exam Success at HGF!

HGF is pleased to announce that several of our attorneys have passed their UK Advanced Patent exams! In no specific order, we would like to say well done and a …

Read article

IP Ingredients: How food companies are using IP to stay ahead of the GLP-1 curve

The impact of GLP-1 on the food and beverage sector GLP-1 agonists, best-known under the brand names Ozempic® and Wegovy®, are medicines used to treat type 2 diabetes and obesity. …

Read article
See all updates